<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-nutrients-10-00783" class="ref">
 <label class="label">6.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lian</surname>
    <given-names class="given-names">L.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Bai</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wu</surname>
    <given-names class="given-names">Y.L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wan</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Xie</surname>
    <given-names class="given-names">W.X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jin</surname>
    <given-names class="given-names">X.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nan</surname>
    <given-names class="given-names">J.X.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Cryptotanshinone inhibits LPS-induced proinflammatory mediators via TLR4 and TAK1 signaling pathway</article-title>
  <source class="source">Int. Immunopharmacol.</source>
  <year class="year">2011</year>
  <volume class="volume">11</volume>
  <fpage class="fpage">1871</fpage>
  <lpage class="lpage">1876</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.intimp.2011.07.018</pub-id>
  <?supplied-pmid 21835267?>
  <pub-id pub-id-type="pmid" class="pub-id">21835267</pub-id>
 </element-citation>
</ref>
